The National Coalition on Health Care is spearheading an effort to get drug makers to disclose how much they spend inventing drugs and their rationale for drug prices. The broad-based stakeholder group is trying to set up a meeting with the drug industry and other stakeholders to figure out how the transparency measures would work, but a Pharmaceutical Research and Manufacturers of America official indicated that the drug trade group is not interest in negotiating. In May, America's Health Insurance...